First reported by BakeryAndSnacks
Obesity in retreat as GLP-1 use nearly quadruples: New data paints a different picture for manufacturers
GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds
From the article
A new Gallup survey reveals that 11% of U.S. adults currently take GLP-1 medications for weight loss, a sharp rise from just 3% in 2024. The figure climbed steadily, moving from 3% in 2024 to 8% in 2025, before reaching the current 11% recorded in the latest survey conducted in mid-2026. Gallup also found that […] The post GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds appeared first on Foreign Policy Journal .
Continue reading on Foreign Policy JournalYou might also wanna read
Obesity in retreat as GLP-1 use nearly quadruples: New data paints a different picture for manufacturers
BakeryAndSnacks·3h ago
GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr
gizmodo.com·1mo ago
More Americans Than Ever Are Taking Weight-Loss Drugs
NYT·2d ago
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research published in the Journal of Clinical Oncology suggests GLP-1 weight loss medications may reduce cancer risk. An observational s
forbes.com·25d ago
Study: Over Half of Binge Eating Disorder Patients Have Used GLP-1 Weight-Loss Drugs
A study published in JAMA Psychiatry reveals that over half of patients with binge eating disorder and one-third with atypical anorexia nerv
mdsc.pe·9d ago
Study: GLP-1 Weight Loss Drugs Linked to Decline in Daily Physical Activity
A new study analyzing NIH All of Us Research Program data, including Fitbit activity records and electronic health records, reveals that adu
neurosciencenews.com·24d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.